Fundalysisby DARKHORSESTOCKS

Scheme

DSP Healthcare Fund

Holds 31 companies worth ₹3,457 Cr in Sept 2026.

  • Fund house

    DSPThe fund house that runs this scheme.

  • AUM

    ₹3,750 CrDSP Healthcare Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 2.2% on Aug 2026, ₹3,835 Cr.

  • Largest holding

    IPCA Laboratories LimitedIPCA Laboratories Limited is 8.1% of this scheme's NAV.

  • Fund manager

    Chirag DagliRuns it since 1 Dec 2020, as the fund house dates it.

Overview(6 Oct 2026)

Fund managers1

  1. Chirag DagliFund manager, equity · Dec 2020 · 22y · CA B.Com

    Key facts

    Benchmark
    BSE Healthcare TRI
    Risk
    Very High
    Expense
    Regular 2.05% · Direct 0.75%
    Exit load
    Holding period from the date of allotment: <= 1 month - 0.50% >1 month Nil (as a % of Applicable NAV)
    Started
    30 Nov 2018
    Minimum
    ₹100

    Source.Its Scheme Summary Document as of 6 Oct 2026 at AMFI.

    What changed(60 changes)

    Oct 2026

    1 change
    1. Exit load
      6 Oct0.50% - Holding period from the date of allotment <= 1 month, Nil - Holding period from the date of allotment > 1 month (as a % of Applicable NAV) → Holding period from the date of allotment: <= 1 month - 0.50% >1 month Nil (as a % of Applicable NAV)

    Sept 2026

    1 change
    1. Expense ratio
      8 SeptDirect 0.74% → 0.75%

    Aug 2026

    3 changes
    2. Category
      26 AugSectoral/Thematic Funds → Sectoral Fund

    Source.Its filings at NSE, since Aug 2024.

    Fund managers over time(Dec 2020 – now)

    1. Chirag Dagli
    MainCoSlice202120222023202420252026
    Fig. 1.Who ran it when: each manager from the date the fund house gives, or the first document listing them where it gives none, to when they left. A slice is part of it: overseas, gold and silver, or arbitrage.

    Costs(Aug 2024 – Oct 2026)

    Every change to the expense ratio, newest first.
    59 changesRegularDirectΔ pt
    8 Sept 20262.05%0.75%0.01
    31 Aug 20262.05%0.74%0.01
    12 Aug 20262.04%0.73%0.02
    28 Jul 20262.02%0.71%0
    17 Jul 20262.01%0.71%0.02
    8 Jul 20262.01%0.69%0.01
    1 Jul 20262.02%0.70%0.10
    18 Jun 20261.92%0.60%0.01
    17 Jun 20261.93%0.61%0.13
    16 Jun 20262.06%0.74%0.21
    15 Jun 20262.28%0.95%0.35
    25 May 20261.92%0.60%0
    20 May 20261.93%0.60%0.03
    19 May 20261.96%0.63%0.03
    18 May 20261.92%0.60%0.28
    17 May 20262.20%0.88%0.20
    13 May 20262.00%0.68%0.07
    10 May 20261.92%0.61%0.39
    7 May 20262.33%1.00%0.10
    6 May 20262.22%0.90%0.21
    5 May 20262.43%1.11%0.14
    3 May 20262.56%1.25%0.46
    29 Apr 20262.12%0.79%0.12
    28 Apr 20261.99%0.67%0.06
    26 Apr 20261.94%0.61%0.03
    23 Apr 20261.97%0.64%0.02
    20 Apr 20261.98%0.66%0.04
    23 Mar 20261.94%0.62%0.04
    4 Mar 20261.95%0.66%0.01
    1 Feb 20261.94%0.65%0.02
    29 Jan 20261.94%0.63%0.01
    12 Jan 20261.93%0.62%0.03
    23 Dec 20251.92%0.59%0
    21 Dec 20251.93%0.59%0.01
    16 Dec 20251.93%0.60%0.01
    1 Dec 20251.92%0.59%0.03
    10 Oct 20251.91%0.56%0.01
    3 Oct 20251.92%0.57%0.03
    29 Sept 20251.93%0.60%0.01
    8 Aug 20251.92%0.59%0.02
    6 Aug 20251.92%0.57%0.01
    21 Jul 20251.91%0.56%0.01
    15 Jul 20251.92%0.57%0.01
    30 Jun 20251.93%0.58%0.03
    5 Jun 20251.93%0.61%0.01
    29 Apr 20251.94%0.62%0.03
    8 Apr 20251.95%0.65%0.01
    4 Apr 20251.94%0.64%0.01
    3 Mar 20251.93%0.63%0.04
    14 Feb 20251.92%0.59%0.01
    13 Jan 20251.91%0.58%0.01
    27 Dec 20241.90%0.57%0.01
    13 Dec 20241.91%0.58%0.01
    4 Nov 20241.92%0.59%0.01
    22 Oct 20241.93%0.60%0.01
    11 Oct 20241.92%0.59%0.01
    26 Sept 20241.93%0.60%0.04
    4 Sept 20241.93%0.56%0.01
    21 Aug 20241.94%0.57%–
    Direct plan, 8 Sept 2026
    0.75%
    Regular plan 2.05% · Exit load Holding period from the date of allotment: <= 1 month - 0.50% >1 month Nil (as a % of Applicable NAV)
    Fig. 1.Total expense ratio a year, each plan's, as its Scheme Summary Documents state it, filing by filing at NSE. A change holds until the next.

    Objective and risk(6 Oct 2026)

    Objective

    The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies/entities. There is no assurance that the investment objective of the Scheme will be achieved.

    Risk, type and benchmark

    Riskometer
    Very High
    At launch
    Very High
    Type
    An open ended equity scheme investing in healthcare and pharmaceutical sector
    Benchmark
    BSE Healthcare TRI

    Asset allocation it may hold% of NAV

    1. 1. Equity and Equity related Instruments of Pharmaceutical and Healthcare companies / entities
      Allowed80–100%Holds92.2%
    2. 2. Other Equity and Equity related Instruments/ Money Market Instruments / InvITs/ Gold ETFs / Silver ETFs / Other Liquid Instruments / Units of Domestic Mutual Funds
      Allowed0–20%

    Holds in Sept 2026.92.2% equity · 7.8% debt and cash

    How to invest(6 Oct 2026)

    Buying

    To start
    ₹100, then in multiples of ₹1
    To add
    ₹100, then in multiples of ₹1
    Systematic
    SIP Daily, Weekly, Monthly, Quarterly, Half-Yearly and Yearly SWP Weekly, Monthly, Quarterly, Half-Yearly and Yearly STP Daily, Weekly, Monthly, Quarterly, Half-Yearly and Yearly *Weekly Monday to Friday
    Dates
    Any date
    Minimum
    ₹100, then in multiples of ₹1
    Instalments
    SIP - 12, SWP & STP - 6

    Selling and switching

    To redeem
    ₹0.01 or 0.001 units
    Switch minimum
    ₹100 or 0.001 units
    Switch multiples
    ₹0.01 or 0.001 units

    Scheme details(6 Oct 2026)

    What it is

    Category
    Sectoral Fund
    Offer
    12 Nov 2018 to 26 Nov 2018
    Started
    30 Nov 2018
    Reopened
    4 Dec 2018
    Plans
    Regular Plan & Direct Plan Growth (Option A) Income Distribution cum Capital Withdrawal option (IDCW) (Option B) - Payout of Income Distribution cum Capital Withdrawal (IDCW) - Reinvestment of Income Distribution cum Capital Withdrawal (IDCW) Default Option - Growth Option in case Growth Option or Income Distribution cum Capital Withdrawal (IDCW) Option is not indicated. - Payout sub-option in case Payout of IDCW Option or Reinvestment of IDCW Option is not indicated.
    Face value
    ₹10
    Listed
    No

    How it is run

    Swing pricing
    No
    Side-pocketing
    No
    Custodian
    HSBC
    Auditor
    S.R. Batliboi & Co LLP
    Registrar
    Computer Age Management Services Limited
    SEBI code
    DSPM/O/E/SEC/18/05/0035